2 comments

[ 2.8 ms ] story [ 12.3 ms ] thread
Looks interesting. I am in no way targeted audience, but can you share some of your motivation to work on this?
Our motivation came primarily from the firsthand experience of the sister of one of our cofounders; as a researcher conducting trials herself, she saw the inefficiency and bureaucracy involved in managing them.

We are also concerned about scientific reproducibility as a whole, as well as data alteration. For example, even large companies like GlaxoSmithKline [0] have been caught tampering with clinical data, and the effects for those taking the drugs can be deadly.

We believe Delphus can solve these issues, giving patients more transparency and trust in the research they participate in.

[0]: https://www.nytimes.com/2012/07/03/business/glaxosmithkline-...